This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Alzheimer Disease  • Dementias  • Bipolar Disorder  • Psychopharmacology  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Lars Vedel Kessing, MD, DMSc; Lars Søndergård, MD, PhD; Julie Lyng Forman, MSc, PhD; Per Kragh Andersen, MSc, PhD, DMSc

Arch Gen Psychiatry. 2008;65(11):1331-1335.

Context  It has been suggested that lithium may have neuroprotective abilities, but it is not clear whether lithium reduces the risk of dementia.

Objective  To investigate whether continued treatment with lithium reduces the risk of dementia in a nationwide study.

Design  An observational cohort study with linkage of registers of all patients prescribed lithium and diagnosed as having dementia in Denmark from January 1, 1995, through December 31, 2005.

Setting  We identified all patients treated with lithium in Denmark within community psychiatry, private specialist, and general practices and a random sample of 30% of the general population.

Subjects  A total of 16 238 persons who purchased lithium at least once and 1 487 177 persons from the general population who did not purchase lithium.

Main Outcome Measure  Diagnosis of dementia or Alzheimer disease during inpatient or outpatient hospital care.

Results  Persons who purchased lithium at least once had an increased rate of dementia compared with persons not exposed to lithium (relative risk, 1.47; 95% confidence interval, 1.22-1.76). For persons who continued to take lithium, the rate of dementia decreased to the same level as the rate for the general population. The rate of dementia decreased early after the consumption of lithium tablets corresponding to 1 prescription (typically 100 tablets) and stayed at a low level, although with a slight increase according to the number of subsequent prescriptions. The association between the number of prescriptions for lithium and dementia was unique and different from the association between the number of prescriptions for anticonvulsants and dementia. All findings were replicated in subanalyses with Alzheimer disease as the outcome.

Conclusions  Continued lithium treatment was associated with reduction of the rate of dementia to the same level as that for the general population. Methodological reasons for this finding cannot be excluded, owing to the nonrandomized nature of data.

Author Affiliations: Department of Psychiatry, Rigshospitalet, University Hospital of Copenhagen (Drs Kessing and Søndergård), and Department of Biostatistics, University of Copenhagen (Drs Forman and Andersen), Copenhagen, Denmark.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of General Psychiatry
Arch Gen Psychiatry. 2008;65(11):1243.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sentinels on the road to disaster.
Tyrer
Br. J. Psychiatry 2009;195:378-378.
FULL TEXT  

Does Lithium Protect Against Dementia?
JWatch Psychiatry 2008;2008:2-2.
FULL TEXT